• Z-VAD-FMK: Mechanisms and Evidence for Pan-Caspase Inhibitio

  2026-05-09

  Z-VAD-FMK is an irreversible, cell-permeable pan-caspase inhibitor essential for apoptosis pathway research. Its specificity and proven effects in models such as THP-1 and Jurkat T cells underpin its benchmark role in dissecting caspase-dependent cell death. APExBIO’s A1902 kit remains a standard for reproducible inhibition of caspase-mediated apoptosis.

• Bradykinin B2 Receptors Inhibit Ileal Peristalsis: Study Ins

  2026-05-08

  This study provides the first direct evidence that bradykinin B2 receptors mediate inhibition of the peristaltic reflex in the guinea pig isolated ileum. The findings clarify the receptor subtype responsible for bradykinin’s effects on gut motility, offering a mechanistic reference point for research into gastrointestinal regulation and potential pharmacological interventions.

• High Tumor Fluid Viscosity Drives P-gp–Mediated Chemoresista

  2026-05-08

  This study uncovers how elevated extracellular fluid viscosity in the tumor microenvironment upregulates P-glycoprotein (P-gp), promoting chemoresistance through a mechanotransduction cascade involving TRPV4 and YAP signaling. The findings emphasize the importance of mechanical cues in cancer biology and highlight potential targets for overcoming drug resistance.

• PR-619: Practical Use of a Broad-Spectrum DUB Inhibitor

  2026-05-07

  PR-619 is a cell-permeable, reversible deubiquitylating enzymes inhibitor designed for targeted modulation of ubiquitination without direct proteasome inhibition. It is best applied in cell-based assays investigating DUB activity, autophagic flux, or protein aggregation in cancer and neurodegeneration models. This compound should not be used where aqueous or ethanol solubility is required, or for studies reliant on selective DUB targeting.

• Sodium Ascorbate in Cancer Research: Mechanisms, Protocols &

  2026-05-07

  Explore the unique roles of Sodium Ascorbate, a mineral salt of ascorbic acid, in advanced cancer research. This in-depth analysis unveils mechanistic insights, rigorous protocol guidance, and next-generation applications that set a new benchmark beyond existing guides.

• Spiroplasma eriocheiris Entry into Drosophila S2 Cells: Path

  2026-05-06

  This study reveals that Spiroplasma eriocheiris invades Drosophila Schneider 2 (S2) cells predominantly via clathrin-mediated endocytosis and macropinocytosis, not caveolae-dependent pathways. The findings establish the essential roles of both microtubules and actin filaments in S. eriocheiris infection, providing a robust cellular model for dissecting host-pathogen interactions relevant to invertebrate and crustacean disease.

• Astrocyte Transcriptomic Diversity Across Brain Regions and

  2026-05-06

  Schroeder et al. provide a comprehensive transcriptomic atlas revealing how astrocyte regional heterogeneity evolves during postnatal development in mouse and marmoset brains. This work illuminates conserved and divergent molecular signatures and links regional gene expression changes to morphological specialization, advancing our understanding of glial diversity and brain circuit formation.

• Anlotinib Hydrochloride: Multi-Target Tyrosine Kinase Inhibi

  2026-05-05

  Anlotinib hydrochloride revolutionizes angiogenesis assays by providing potent, selective, and low-toxicity inhibition of VEGFR2, PDGFRβ, and FGFR1. Its robust pharmacological and workflow profile, validated by recent preclinical studies, uniquely positions it as the TKI of choice for advanced cancer research and translational models.

• XXLP Modulates NOX2/ROS/Mitochondria/NLRP3 Axis in Colitis M

  2026-05-05

  Xu Chunfu’s Modified Xianglian Pill (XXLP) demonstrates significant anti-inflammatory effects in ulcerative colitis by targeting the NOX2/ROS/mitochondria/NLRP3 axis and reshaping gut microbiota. This mechanistic evidence provides a foundation for integrative therapeutic strategies in inflammatory bowel disease research.

• Dextran Sulfate Sodium Salt: Mechanisms and Strategy in IBD

  2026-05-04

  This thought-leadership article for translational researchers explores the mechanistic foundations and strategic application of Dextran sulfate sodium salt (MW 35000-45000) in mouse models of inflammatory bowel disease. By integrating recent advances in epithelial repair circuitry and leveraging APExBIO’s SKU B8205, the article delivers actionable guidance for building robust, translationally relevant preclinical workflows. The piece uniquely bridges mechanistic insight—such as the GPR35-KLF5 axis in mucosal repair—with protocol optimization and future outlook.

• BipD-Mediated Hijacking of Host E3 Ligase Drives Mitophagy i

  2026-05-04

  This study reveals how Burkholderia pseudomallei uses its BipD protein to hijack host KLHL9/KLHL13/CUL3 E3 ligase, leading to IMMT ubiquitination and mitophagy. The findings clarify a novel bacterial evasion mechanism and suggest new molecular targets for host-pathogen research.

• Adiponectin Mitigates Post-Surgical Cognitive Deficits via T

  2026-05-03

  This study demonstrates that adiponectin administration alleviates neuroinflammation and oxidative stress following splenectomy in aged rats by inhibiting the TLR4/MyD88/NF-κB signaling pathway. These findings offer mechanistic insights into perioperative neurocognitive disorder and suggest new directions for therapeutic intervention in age-related cognitive decline.

• MK 0893: Potent Glucagon Receptor Antagonist for Diabetes Re

  2026-05-02

  MK 0893 is a potent, selective glucagon receptor antagonist that inhibits cAMP production and reduces glucose excursion in preclinical and clinical type 2 diabetes models. Its unique allosteric binding ensures high selectivity and nanomolar efficacy, with robust validation in both animal and human studies.

• Astrocyte Heterogeneity Mapped Across Brain Regions and Ages

  2026-05-01

  This study presents a cross-species, developmental transcriptomic atlas revealing the evolving regional and molecular diversity of astrocytes in mouse and marmoset brains. The findings illuminate conserved and divergent gene expression signatures and highlight the importance of spatial and temporal context in glial cell biology.

• Ginsenoside Rg1 Restores Neuroimmune Balance After Isofluran

  2026-05-01

  This study demonstrates that Ginsenoside Rg1, a triterpene saponin from Panax species, reverses neuroimmune and cognitive disruptions induced by prolonged isoflurane anesthesia in mice via regulatory T cell-dependent mechanisms. These findings point to a promising strategy for mitigating post-anesthetic neuroimmune complications and support further research into the gut-immune-brain axis.

15548 records 1/1037 page Next 12345 下5页 Last page